Table 2.
Cessation of benzodiazepine use in the three groups at 12 months and 36 months
| 12 months | 36 months | |||||||
|---|---|---|---|---|---|---|---|---|
| Cessation of BZD, n/N (%) | RR | 95% CI | P-value | Cessation of BZD, n/N (%) | RR | 95% CI | P-value | |
| Control group | 26/173 (15.0) | – | – | – | 45/173 (26.0) | – | – | – |
| SIW group | 76/168 (45.2) | 3.01 | 2.03 to 4.46 | <0.0001 | 66/168 (39.2) | 1.51 | 1.10 to 2.05 | 0.009 |
| SIF group | 86/191 (45.0) | 3 | 2.04 to 4.40 | <0.0001 | 79/191 (41.3) | 1.59 | 1.15 to 2.19 | 0.005 |
BZD = benzodiazepine. RR = relative risk. SIF = intervention group with follow-up visits. SIW = intervention group with written instructions.